Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia

Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 pat...

Full description

Bibliographic Details
Main Authors: Jing Zhou, Zhu-Feng Peng, Pan Song, Lu-Chen Yang, Zheng-Huan Liu, Shuai-Ke Shi, Lin-Chun Wang, Jun-Hao Chen, Liang-Ren Liu, Qiang Dong
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Asian Journal of Andrology
Subjects:
Online Access:http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=3;spage=356;epage=360;aulast=
_version_ 1797824512378535936
author Jing Zhou
Zhu-Feng Peng
Pan Song
Lu-Chen Yang
Zheng-Huan Liu
Shuai-Ke Shi
Lin-Chun Wang
Jun-Hao Chen
Liang-Ren Liu
Qiang Dong
author_facet Jing Zhou
Zhu-Feng Peng
Pan Song
Lu-Chen Yang
Zheng-Huan Liu
Shuai-Ke Shi
Lin-Chun Wang
Jun-Hao Chen
Liang-Ren Liu
Qiang Dong
author_sort Jing Zhou
collection DOAJ
description Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 patients, and the conventional program was applied to 238 patients. After 1 year of follow-up, the differences between the ERAS group and the conventional group were evaluated. The ERAS group had a shorter time of urinary catheterization compared with the conventional group (mean ± standard deviation [s.d.]: 1.0 ± 0.4 days vs 2.7 ± 0.8 days, P < 0.01), and the pain (mean ± s.d.) was significantly reduced through postoperative hospitalization days (PODs) 0–2 (POD 0: 1.7 ± 0.8 vs 2.4 ± 1.0, P < 0.01; POD 1: 1.6 ± 0.9 vs 3.5 ± 1.3, P < 0.01; POD 2: 1.2 ± 0.7 vs 3.0 ± 1.3, P < 0.01). No statistically significant difference was found in the rate of postoperative complications, such as postoperative bleeding (P = 0.79), urinary retention (P = 0.40), fever (P = 0.55), and readmission (P = 0.71). The hospitalization cost of the ERAS group was similar to that of the conventional group (mean ± s.d.: 16 927.8 ± 5808.1 Chinese Yuan [CNY] vs 17 044.1 ± 5830.7 CNY, P =0.85). The International Prostate Symptom Scores (IPSS) and quality of life (QoL) scores in the two groups were also similar when compared at 1 month, 3 months, 6 months, and 12 months after discharge. The ERAS program we conducted was safe, repeatable, and efficient. In conclusion, patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program.
first_indexed 2024-03-13T10:39:04Z
format Article
id doaj.art-7332d17ed85b4ba98afa81c092a4f963
institution Directory Open Access Journal
issn 1008-682X
1745-7262
language English
last_indexed 2024-03-13T10:39:04Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Andrology
spelling doaj.art-7332d17ed85b4ba98afa81c092a4f9632023-05-18T04:59:34ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622023-01-0125335636010.4103/aja202267Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasiaJing ZhouZhu-Feng PengPan SongLu-Chen YangZheng-Huan LiuShuai-Ke ShiLin-Chun WangJun-Hao ChenLiang-Ren LiuQiang DongEnhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 patients, and the conventional program was applied to 238 patients. After 1 year of follow-up, the differences between the ERAS group and the conventional group were evaluated. The ERAS group had a shorter time of urinary catheterization compared with the conventional group (mean ± standard deviation [s.d.]: 1.0 ± 0.4 days vs 2.7 ± 0.8 days, P < 0.01), and the pain (mean ± s.d.) was significantly reduced through postoperative hospitalization days (PODs) 0–2 (POD 0: 1.7 ± 0.8 vs 2.4 ± 1.0, P < 0.01; POD 1: 1.6 ± 0.9 vs 3.5 ± 1.3, P < 0.01; POD 2: 1.2 ± 0.7 vs 3.0 ± 1.3, P < 0.01). No statistically significant difference was found in the rate of postoperative complications, such as postoperative bleeding (P = 0.79), urinary retention (P = 0.40), fever (P = 0.55), and readmission (P = 0.71). The hospitalization cost of the ERAS group was similar to that of the conventional group (mean ± s.d.: 16 927.8 ± 5808.1 Chinese Yuan [CNY] vs 17 044.1 ± 5830.7 CNY, P =0.85). The International Prostate Symptom Scores (IPSS) and quality of life (QoL) scores in the two groups were also similar when compared at 1 month, 3 months, 6 months, and 12 months after discharge. The ERAS program we conducted was safe, repeatable, and efficient. In conclusion, patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program.http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=3;spage=356;epage=360;aulast=aging male; benign prostatic hyperplasia; enhanced recovery after surgery; prostate; transurethral surgery
spellingShingle Jing Zhou
Zhu-Feng Peng
Pan Song
Lu-Chen Yang
Zheng-Huan Liu
Shuai-Ke Shi
Lin-Chun Wang
Jun-Hao Chen
Liang-Ren Liu
Qiang Dong
Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
Asian Journal of Andrology
aging male; benign prostatic hyperplasia; enhanced recovery after surgery; prostate; transurethral surgery
title Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
title_full Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
title_fullStr Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
title_full_unstemmed Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
title_short Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
title_sort enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
topic aging male; benign prostatic hyperplasia; enhanced recovery after surgery; prostate; transurethral surgery
url http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=3;spage=356;epage=360;aulast=
work_keys_str_mv AT jingzhou enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT zhufengpeng enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT pansong enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT luchenyang enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT zhenghuanliu enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT shuaikeshi enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT linchunwang enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT junhaochen enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT liangrenliu enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia
AT qiangdong enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia